Camille Evrard

998 total citations
19 papers, 393 citations indexed

About

Camille Evrard is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Camille Evrard has authored 19 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 9 papers in Cancer Research. Recurrent topics in Camille Evrard's work include Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). Camille Evrard is often cited by papers focused on Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). Camille Evrard collaborates with scholars based in France and Belgium. Camille Evrard's co-authors include David Tougeron, Violaine Randrian, Gaëlle Tachon, Lucie Karayan‐Tapon, Jérôme Alexandre, Audelaure Junca, É. Frouin, Paul de Boissieu, Louis de Mestier and Catherine Lombard‐Bohas and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, BMC Cancer and Cancers.

In The Last Decade

Camille Evrard

15 papers receiving 386 citations

Peers

Camille Evrard

ONCOL

PFM

EPIDE

Chenghao Yi China

Omar Kayaleh United States

Emi Takakuwa Japan

Yanfen Feng China

Aurélie Ferru France

Thomas P. Potjer Netherlands

G. Sébille France

Julian Alexander United States

Tibor Ponnelle France

Levi Sokol United States

Chenghao Yi China

Camille Evrard

216 ×0.9

ONCOL

133 ×0.7

PFM

125 ×0.9

61 ×0.7

EPIDE

83 ×1.1

Citations per year, relative to Camille Evrard Camille Evrard (= 1×) peers Chenghao Yi

Countries citing papers authored by Camille Evrard

Since Specialization

Citations

This map shows the geographic impact of Camille Evrard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Evrard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Evrard more than expected).

Fields of papers citing papers by Camille Evrard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Evrard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Evrard. The network helps show where Camille Evrard may publish in the future.

Co-authorship network of co-authors of Camille Evrard

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Evrard. A scholar is included among the top collaborators of Camille Evrard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Evrard. Camille Evrard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Randrian, Violaine, Camille Evrard, Claire Boyer, et al.. (2025). COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study. BMC Cancer. 25(1). 398–398.

Evrard, Camille, É. Frouin, Valérie Moulin, et al.. (2025). Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer. Therapeutic Advances in Gastroenterology. 18. 1128530351–1128530351.

Evrard, Camille, et al.. (2025). Prognostic and Predictive Value of Microsatellite Instability Analysis in Circulating Tumor DNA Using Digital Droplet PCR for Patients With Microsatellite Instability Colorectal Cancers. Laboratory Investigation. 105(8). 104176–104176.

Bregni, Giacomo, G. Anthoine, Thomas Aparicio, et al.. (2024). Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients. Clinical Colorectal Cancer. 24(1). 101–105. 1 indexed citations

Evrard, Camille, et al.. (2023). An Innovative and Accurate Next-Generation Sequencing–Based Microsatellite Instability Detection Method for Colorectal and Endometrial Tumors. Laboratory Investigation. 104(2). 100297–100297. 2 indexed citations

Evrard, Camille, Pierre Ingrand, Gaëlle Tachon, et al.. (2023). Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study. Digestive and Liver Disease. 55(11). 1562–1572. 7 indexed citations

Puyade, Mathieu, Maxime Pichon, Stéphane Velasco, et al.. (2022). Risk factors for biliary stent infections in malignant biliary obstruction secondary to unresectable malignancies. Supportive Care in Cancer. 30(8). 6937–6946.

Tachon, Gaëlle, Thierry Lecomte, Audelaure Junca, et al.. (2022). HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite Instability. Frontiers in Genetics. 12. 769281–769281. 5 indexed citations

Evrard, Camille, Thomas Aparicio, Émilie Soularue, et al.. (2022). Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59. Biomedicines. 10(5). 1211–1211. 4 indexed citations

10.

Tachon, Gaëlle, Romain Cohen, L. Karayan-Tapon, et al.. (2021). Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer. ESMO Open. 6(3). 100120–100120. 68 indexed citations

11.

Evrard, Camille & Jérôme Alexandre. (2021). Predictive and Prognostic Value of Microsatellite Instability in Gynecologic Cancer (Endometrial and Ovarian). Cancers. 13(10). 2434–2434. 27 indexed citations

12.

Randrian, Violaine, Camille Evrard, & David Tougeron. (2021). Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies. Cancers. 13(12). 3063–3063. 40 indexed citations

13.

Zaanan, Aziz, Julie Henriques, Romain Cohen, et al.. (2020). Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin. JNCI Journal of the National Cancer Institute. 113(4). 496–500. 5 indexed citations

14.

Junca, Audelaure, Gaëlle Tachon, Camille Evrard, et al.. (2020). Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge. Cancers. 12(6). 1482–1482. 18 indexed citations

15.

Mestier, Louis de, Thomas Walter, Camille Evrard, et al.. (2019). Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor. Neuroendocrinology. 110(1-2). 83–91. 44 indexed citations

16.

Mestier, Louis de, Thomas Walter, Hédia Brixi, et al.. (2019). Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses. Neuroendocrinology. 108(4). 343–353. 33 indexed citations

17.

Evrard, Camille, Gaëlle Tachon, Violaine Randrian, Lucie Karayan‐Tapon, & David Tougeron. (2019). Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer. Cancers. 11(10). 1567–1567. 114 indexed citations

18.

Tachon, Gaëlle, Ulrich Cortes, Sébastien Martin, et al.. (2019). Targeted RNA‐sequencing assays: a step forward compared to FISH and IHC techniques?. Cancer Medicine. 8(18). 7556–7566. 12 indexed citations

19.

Rigau, Valérie, et al.. (2001). [HBME-1 immunostaining in thyroid pathology].. PubMed. 21(1). 15–20. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact